Risperidone vs. Bupropion ER Augmentation of SSRIs in Treatment-Resistant Depression - Contacts and Locations

Home

Risperidone vs. Bupropion ER Augmentation of SSRIs in Treatment-Resistant Depression

This study has been completed.

Study NCT00179244. Last updated on January 31, 2008. Information provided by Vanderbilt University

Please refer to this study by its ClinicalTrials.gov identifier: NCT00179244

Locations


United States, Tennessee
	Vanderbilt University Medical Center
	Nashville, Tennessee, United States, 37211

Sponsors and Collaborators

Vanderbilt University

Janssen Pharmaceutica N.V., Belgium

Investigators


Principal Investigator:	Richard C Shelton, MD	Vanderbilt University